Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.

Millwood IY.; Bennett DA.; Walters RG.; Clarke R.; Waterworth D.; Johnson T.; Chen Y.; Yang L.; Guo Y.; Bian Z.; Hacker A.; Yeo A.; Parish S.; Hill MR.; Chissoe S.; Peto R.; Cardon L.; Collins R.; Li L.; Chen Z.; China Kadoorie Biobank Collaborative Group None.

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.

Millwood IY., Bennett DA., Walters RG., Clarke R., Waterworth D., Johnson T., Chen Y., Yang L., Guo Y., Bian Z., Hacker A., Yeo A., Parish S., Hill MR., Chissoe S., Peto R., Cardon L., Collins R., Li L., Chen Z., China Kadoorie Biobank Collaborative Group None.

Original publication

DOI

10.1016/j.jacc.2015.10.056

Type

Journal article

Journal

J Am Coll Cardiol

Publication Date

19/01/2016

Volume

Pages

230 - 231

Keywords

1-Alkyl-2-acetylglycerophosphocholine Esterase, Arterial Occlusive Diseases, Benzaldehydes, China, Coronary Disease, Female, Genetic Predisposition to Disease, Humans, Male, Middle Aged, Oximes, Phospholipase A2 Inhibitors, Stroke